Regeneron Pharmaceuticals | REGN - Ebitda


Regeneron Pharmaceuticals reported $1.66B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
AbbVie USD 6.91B 3.22B Jun/2026
Agenus USD -10.11M 19.02M Mar/2025
Agios Pharmaceuticals USD -109.2M 540K Jun/2026
Alnylam Pharmaceuticals USD 360.27M 114.93M Sep/2026
Amgen USD 5.8B 1.25B Sep/2026
Astellas Pharma JPY 182.02B 53.22B Sep/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Biogen USD 450.8M 198.9M Jun/2026
BioMarin Pharmaceutical USD 54.32M 167.99M Sep/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Incyte USD 778.57M 410.6M Jun/2026
Ionis Pharmaceuticals USD -95.22M 9.99M Sep/2026
J&J USD 8.99B 721M Jun/2026
Kyowa Hakko Kirin JPY 34.07B 19.84B Sep/2026
Merck USD 1.42B 2.97B Jun/2026
Moderna USD -687M 571M Jun/2026
Neurocrine Biosciences USD 375.3M 185.4M Sep/2026
Novartis USD 8.62B 2.14B Sep/2026
Novartis USD 5.36B 45M Sep/2026
Pfizer USD 6.36B 350M Sep/2026
Puma Biotechnology USD 729K 11.36M Jun/2024
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 6.66B 4.99B Sep/2026
Sarepta Therapeutics USD -3.14M 33.31M Sep/2026
Teva Pharmaceutical Industries USD 1.5B 1.02B Sep/2026
Ultragenyx Pharmaceutical USD -61M 94M Jun/2026
United Therapeutics USD 334.2M 20.8M Sep/2026
Vertex Pharmaceuticals USD 888.6M 436.6M Sep/2026